Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Osiris Therapeutics, Inc.    OSIR   US68827R1086

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/10/2014 04/11/2014 04/14/2014 04/15/2014 04/16/2014 Date
13.48(c) 12.6(c) 12.69(c) 12.69(c) 12.54 Last
345 364 361 987 222 413 362 953 116 759 Volume
-5.67% -6.53% +0.71% 0.00% -1.18% Change
More quotes
Company
Osiris Therapeutics, Inc. is a stem cell company, which focuses on developing and marketing products to treat medical conditions in the inflammatory, cardiovascular, orthopedic and wound healing markets. The company operates its business through two segments: Therapeutics and Biosurgery segment.... 
Sector
Biotechnology
Calendar
05/06Shareholder meeting
Surperformance© rating of Osiris Therapeutics, Inc.
Trading Rating : - Investor Rating :
More about the company
Chart OSIRIS THERAPEUTICS, INC.
Duration : Period :
Osiris Therapeutics, Inc. Technical Analysis Chart | OSIR | US68827R1086 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 39,2 M
EBIT 2014 -9,84 M
Net income 2014 -8,71 M
Debt 2014 -
Yield 2014 -
Sales 2015 53,5 M
EBIT 2015 -4,06 M
Net income 2015 -3,48 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 11,1x
Capi. / Sales 2015 8,12x
Capitalization 434 M
More Financials
Latest news on OSIRIS THERAPEUTICS, INC.
04/09 OSIRIS THERAPEUTICS : Announces Receipt of $15 Million Cash Payment for Prochyma..
03/26 OSIRIS THERAPEUTICS : 2nd Annual Regen Med Investor Day
03/26 OSIRIS THERAPEUTICS : Announces Therésa K. Dixon as General Manager of Market Ac..
03/24 OSIRIS THERAPEUTICS : to Present at the 2nd Annual Regen Med Investor Day
03/19 OSIRIS THERAPEUTICS : Reports Change in Tax Benefit Allocation for Fourth Quarte..
03/17 OSIRIS THERAPEUTICS : Recent Study: Prochymal (Crohn's Disease) - Forecast and M..
03/12 OSIRIS THERAPEUTICS : Cartiform® Featured in Presentation at the 2014 American A..
03/11 OSIRIS THERAPEUTICS, INC. : Canaccord Genuity Musculoskeletal Conference
03/11 OSIRIS THERAPEUTICS, INC. : Osiris Therapeutics Reports Change in Tax Benefit Al..
03/11 OSIRIS THERAPEUTICS, INC. : FILES (8-K/A) Disclosing Results of Operations and F..
03/10 OSIRIS THERAPEUTICS, INC. : Osiris Therapeutics to Present at the Canaccord Genu..
03/06 OSIRIS THERAPEUTICS, INC. : Cartiform Showcased in Presentation at the American ..
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Technical analysis
Income Statement Evolution
Osiris Therapeutics, Inc. : Income Statement Evolution
More Financials
EPS Revisions
Osiris Therapeutics, Inc. : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF